CO6710945A2 - Hidrato de tartrato de 1-{(2s)-2-amino-4-[2,4-bis(trifluorometil)-5,8-di-hidrato[3,4-d]pirimidin-7(6h)-il]-4-oxobutil}-5,5-difluoro-piperidin-2-ona - Google Patents

Hidrato de tartrato de 1-{(2s)-2-amino-4-[2,4-bis(trifluorometil)-5,8-di-hidrato[3,4-d]pirimidin-7(6h)-il]-4-oxobutil}-5,5-difluoro-piperidin-2-ona

Info

Publication number
CO6710945A2
CO6710945A2 CO13108961A CO13108961A CO6710945A2 CO 6710945 A2 CO6710945 A2 CO 6710945A2 CO 13108961 A CO13108961 A CO 13108961A CO 13108961 A CO13108961 A CO 13108961A CO 6710945 A2 CO6710945 A2 CO 6710945A2
Authority
CO
Colombia
Prior art keywords
hydrate
oxobutyl
trifluoromethyl
bis
amino
Prior art date
Application number
CO13108961A
Other languages
English (en)
Inventor
Ki Sook Park
Jung Min Yun
Bong Chan Kim
Kyu Young Kim
Ji Hye Lee
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45995015&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6710945(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of CO6710945A2 publication Critical patent/CO6710945A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere al 1,5 hidrato de tartrato de 1-{(2S)-2-amino-4-[2,4-bis(trifluorometil)-5,8- dihidropirido [3, 4-d]pirimidin-7 (6H) -il] -4-oxobutil}-5, 5- difluoropiperidin-2-ona, un proceso para prepararlo, y una composición farmacéutica para inhibir la DPP-IV, que comprende dicho compuesto como componente activo.
CO13108961A 2010-11-01 2013-04-30 Hidrato de tartrato de 1-{(2s)-2-amino-4-[2,4-bis(trifluorometil)-5,8-di-hidrato[3,4-d]pirimidin-7(6h)-il]-4-oxobutil}-5,5-difluoro-piperidin-2-ona CO6710945A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20100107868 2010-11-01

Publications (1)

Publication Number Publication Date
CO6710945A2 true CO6710945A2 (es) 2013-07-15

Family

ID=45995015

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13108961A CO6710945A2 (es) 2010-11-01 2013-04-30 Hidrato de tartrato de 1-{(2s)-2-amino-4-[2,4-bis(trifluorometil)-5,8-di-hidrato[3,4-d]pirimidin-7(6h)-il]-4-oxobutil}-5,5-difluoro-piperidin-2-ona

Country Status (28)

Country Link
US (1) US8859567B2 (es)
EP (1) EP2635580B1 (es)
JP (1) JP6193762B2 (es)
KR (1) KR101446789B1 (es)
CN (1) CN103189375B (es)
AP (1) AP3287A (es)
AR (1) AR083591A1 (es)
AU (1) AU2011324253B2 (es)
BR (1) BR112013010586A2 (es)
CA (1) CA2814357C (es)
CL (1) CL2013001137A1 (es)
CO (1) CO6710945A2 (es)
DO (1) DOP2013000090A (es)
EA (1) EA024679B1 (es)
EC (1) ECSP13012599A (es)
GE (1) GEP20156218B (es)
IL (1) IL225808A (es)
MA (1) MA34625B1 (es)
MX (1) MX341584B (es)
MY (1) MY156428A (es)
NZ (1) NZ609644A (es)
PE (3) PE20180464A1 (es)
SG (1) SG189931A1 (es)
TW (1) TWI519533B (es)
UA (1) UA106445C2 (es)
UY (1) UY33696A (es)
WO (1) WO2012060590A2 (es)
ZA (1) ZA201302646B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2007752E (pt) 2006-03-31 2010-10-18 Janssen Pharmaceutica Nv Benzoimidazol-2-il pirimidinas e pirazinas como moduladores do receptor de histamina h4
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
MY180726A (en) 2013-03-06 2020-12-08 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE451369T1 (de) * 2002-07-15 2009-12-15 Merck & Co Inc Piperidinopyrimidindipeptidylpeptidaseinhibitor n zur behandlung von diabetes
US7388019B2 (en) 2003-01-31 2008-06-17 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
TWI357902B (en) 2005-04-01 2012-02-11 Lg Life Science Ltd Dipeptidyl peptidase-iv inhibiting compounds, meth

Also Published As

Publication number Publication date
US20130203787A1 (en) 2013-08-08
ECSP13012599A (es) 2013-07-31
GEP20156218B (en) 2015-01-12
SG189931A1 (en) 2013-06-28
MA34625B1 (fr) 2013-10-02
AU2011324253A1 (en) 2013-05-02
PE20140392A1 (es) 2014-03-22
MY156428A (en) 2016-02-26
AU2011324253B2 (en) 2015-10-29
WO2012060590A3 (en) 2012-06-28
ZA201302646B (en) 2014-01-29
PE20240220A1 (es) 2024-02-16
MX341584B (es) 2016-08-25
EP2635580A2 (en) 2013-09-11
CN103189375A (zh) 2013-07-03
EP2635580B1 (en) 2015-08-12
UA106445C2 (ru) 2014-08-26
AP2013006866A0 (en) 2013-05-31
TWI519533B (zh) 2016-02-01
EA024679B1 (ru) 2016-10-31
CL2013001137A1 (es) 2013-09-06
MX2013004776A (es) 2013-11-04
JP6193762B2 (ja) 2017-09-06
PE20180464A1 (es) 2018-03-06
KR20120046069A (ko) 2012-05-09
US8859567B2 (en) 2014-10-14
IL225808A (en) 2016-08-31
EP2635580A4 (en) 2014-04-02
AP3287A (en) 2015-05-31
EA201390644A1 (ru) 2014-11-28
UY33696A (es) 2012-04-30
CA2814357A1 (en) 2012-05-10
CN103189375B (zh) 2016-08-10
BR112013010586A2 (pt) 2016-08-09
KR101446789B1 (ko) 2014-10-01
NZ609644A (en) 2016-02-26
CA2814357C (en) 2015-07-07
AR083591A1 (es) 2013-03-06
JP2013540810A (ja) 2013-11-07
WO2012060590A2 (en) 2012-05-10
TW201245189A (en) 2012-11-16
DOP2013000090A (es) 2018-06-30
IL225808A0 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
GT201300137A (es) Derivados de imidazo [1,2-b] piridazina e imidazo [4,5-b] piridina como inhibidores de jak
UY34870A (es) Cristales de sal
CL2012000589A1 (es) Compuestos derivados de pirrolo piridin carboxamidas, inhibidores de jak2; composición farmacéutica que los comprende; uso en el tratamiento de enfermedades mieloproliferativas o cáncer, tales como policitemia vera, trombocitopenia esencial, mieloma múltiple, entre otras.
CL2012002270A1 (es) Compuestos derivados de pirrolo[2,3-d]-pirimidina composición farmacéutica que los comprende; utiles en el tratamiento del cancer.
CO6531451A2 (es) Compuesto de pirrolo[2,3-d]pirimidina
GT201500094A (es) Derivados de pirrolotriazinona como inhibidores de pi3k
UY33503A (es) Imidazo [1,2-a]pirimidinas y piridinas sustituidas
CL2012000248A1 (es) Compuesto conjugado de insulina; procedimiento de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; kit farmaceutico; uso en el tratamiento de trastornos mediados por insulina.
DK3489238T3 (da) Farmaceutiske sammensætninger af 6h-pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5-on- og [1,2,4]triazolo[1,5-c]pteridin-5(6h)-on-derivater som pde1-inhibitorer til behandling af for eksempel neurologiske lidelser
JO3111B1 (ar) ترايازولوبيريدينات مستبدلة واستخدامها كمثبطات ttk
UY33801A (es) COMPUESTOS SUSTITUIDOS DE N-(1H-INDAZOL-4IL)IMIDAZO[1,2-a]PIRIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE LA TIROSINA QUINASA RECEPTORA DE TIPO III
BR112014029708A2 (pt) composto de pirrolo[2,1-f][1,2,4]triazina, método de preparação de compostos de pirrolo[2,1-f][1,2,4]triazina e uso do composto de pirrolo[2,1-f][1,2,4]triazina
CL2010001488A1 (es) Proceso para preparar 2,4-dioxo-1,2,4-tetrahidropirido[2,3-d]pirimidin-7-il-fenil sustituido y 2,4-bis[3-metilmorfolin-4-il]pirido[2,3-d]pirimidin-7-il-fenil-sustituido; sal fumarato de {5-[2,4-bis[(3s)-3-metilmorfolin-4-il]pirido[2,3-d]pirimidin-7-il]-2-metoxifenil}metanol; composicon farmaceutica; y uso para tratar el cancer.
CU20120081A7 (es) Nuevas formas polimorfas de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}carbamato de metilo
BR112012019302A2 (pt) imidazo[1,2-b][1,2,4]triazinas como inibidores de c-met
BR112016008994A2 (pt) Compostos de pirido[2,3-d]pirimidin-4-ona como inibidores de tanquirase
ECSP13012599A (es) Hidrato de tartrato DE 1-{(2S)-2-amino-4-[2,4-bis(trifluorometil)-5,8-di-hidropirido[3,4-d]pirimidin-7(6H)-il]-4-oxobutil}-5,5-difluoro-piperidin-2-ona
CR20110023A (es) Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida
TN2013000161A1 (en) Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
NI201200162A (es) Inhibidores de pirazolil quinoxalina cinasa
CU24344B1 (es) Imidazo[1,2-a]piridincarboxamidas aminosustituidas